Before evidence of benefit, telehealth platforms push multi-cancer detection tests

Widespread use could catch some cancers early — or give patients false reassurance. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

February 6, 2026 Check out STAT+

Sponsored By

Camille MacMillin/STAT The push to turn Big Food into the new Big Tobacco RFK Jr. and his MAHA allies say food companies have made ultra-processed foods addictive. Food industry lobbyists call the claims inaccurate and risky By Sarah Todd STAT+ | White House looks for more drug pricing deals to add to TrumpRx The Trump administration is working to get more companies to offer prescription drugs at discounted cash prices on TrumpRx. By Daniel Payne STAT+ | Hims, other telehealth platforms push multi-cancer detection tests before evidence of benefit Multi-cancer blood tests promise early detection, but experts warn of misleading patients with false negatives or unneeded care with false positives. By Katie Palmer Jeff Roberson Amid federal pressure, more hospitals stop gender-affirming care for minors Trump administration threats of lost funding and investigations have led at least 40 hospitals to restrict gender-affirming care for minors By Theresa Gaffney Statins don't cause most of the side effects on package warnings, study finds A major Lancet review shows most statin side effects listed on drug labels occur just as often with placebo, raising the question of outdated warnings. By Elizabeth Cooney China criticizes U.S. for WHO pullout, accusing it of sidestepping international law China tells WHO major countries "should lead by example," says health agency should change rules and bar countries like the U.S. from leaving at will. By Helen Branswell Joe Raedle/Getty Images Opinion: I treated children for rotavirus in Denmark. The Danish vaccine schedule is no model for the U.S. This pediatrician has worked in Denmark and the U.S. He thinks Denmark should learn from the U.S. on vaccines, not the other way around. By Michael Thwing STAT+ | A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all Four drug companies — Agomab, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public on Nasdaq this week, raising close to $1 billion combined. By Allison DeAngelis Scientists worry finalizing 'Schedule F' rule will further politicize NIH grant decisions Trump's move to strip some civil service protections means federal workers could be fired for 'subverting Presidential directives' By Anil Oza

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser